InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: A deleted message

Thursday, 07/02/2020 10:54:58 AM

Thursday, July 02, 2020 10:54:58 AM

Post# of 54031
There are a lot of positive potentials;

Retail

Wholesale

Aegea test kit

And the drug trial. I imagine that getting all the ducks in a row with SEC.

I don’t think this will be a long trial if safety data can be piggybacked off approved CBD drug. Patients will know in a matter of a couple weeks whether this helps with nausea or not.

VTGN has gotten more interesting for TAUG also. I think TAUG controls well over 1 million shares when you factor in warrants that are exercisable are .50.

If VTGN does a few more joint ventures like they just announced this will get very interesting. China/Korea is second biggest drug market. VTGN just licensed a phase 3 ready nasal Social anxiety drug for a $5 mil up front non dilutive payment with $172 mil in milestone payments through various points of phase 3 trial. Plus the trial is fully paid for and if successful double digit royalties.

And while the AV 101 missed its 2b endpoint, it looks like a new patent is established using a combination drug to get more drug converted through the blood Breslin barrier. This is the same technique AXSM used when it was trading at $2.00.